1. Elliott LH, McCormick JB, Johnson KM. Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol. 1982 Oct;16(4):704-8.
2. Mitchell SW, McCormick JB. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol 1984; 20(3):486-9.
3. Barbeito MS, Taylor LA, Seiders RW. Microbiologic evaluation of a large volume air incinerator [PDF -6 pages]. Appl Microbiol 1968; 16:490-5.
4. Chepurnova AA, Bakulina LF, Dadaeva AA, Ustinova EN, Chepurnova TS, Baker JR, Jr,. Inactivation of Ebola virus with a surfactant nanoemulssion. Acta Tropica 2003; 87:315-320.
5. CDC Interim Guidance for Environmental Infection Control in Hospitals for Ebola Virus. 2014.
6. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007; 196:S142–7.
7. Ribner BS. Treating patients with Ebola virus infections in the US: lessons learned. Presented at IDWeek, October 8, 2014. Philadelphia PA.
8. Favero MS, Bond WW. Chemical disinfection of medical and surgical materials. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia (PA): Lippincott Williams & Wilkins, 2001:881-917.
9. Mitchell SW, McCormick JB. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol 1984; 20(3):486-9.
10. Russell AD. Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect 1998;43:S57-68.
11. Rutala WA, Weber DA, Healthcare Infection Control Practices Advisory Committee. Guidelines for disinfection and sterilization in healthcare facilities, 2008 [PDF – 158 pages] . Atlanta (GA): Centers for Disease Control and Prevention, 2008.